Skip to main content
John Kriesel, MD, Infectious Disease, Salt Lake City, UT

JohnD.KrieselMD

Infectious Disease • Salt Lake City, UT

ID specialist at University of Utah

Join to view full profile

Dr. Kriesel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kriesel's full profile

Already have an account?

  • Office

    50 N Medical Dr
    Salt Lake City, UT 84132
    Phone+1 801-585-2031

Education & Training

  • University of Utah Health
    University of Utah HealthFellowship, Infectious Disease, 1991 - 1994
  • University of Utah Health
    University of Utah HealthResidency, Internal Medicine, 1988 - 1991
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1988

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 1989 - 2026

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial  
    David I Bernstein, John Kriesel, William Koltun, Gregg Lucksinger, Peter A Leone, Richard Beigi, Stephen Tyring, Richard M Novak, Seth Hetherington, The Journal of Infectious Diseases

Press Mentions

  • Drugmakers Racing to Create Effective Antiviral Pill for COVID-19 Infection
    Drugmakers Racing to Create Effective Antiviral Pill for COVID-19 InfectionSeptember 27th, 2021
  • Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine Trial
    Vical Completes Target Enrollment in Its Phase 2 Therapeutic HSV-2 Vaccine TrialApril 19th, 2017
  • MS Research Takes Center Stage at the Consortium of MS Centers’ Annual Meeting
    MS Research Takes Center Stage at the Consortium of MS Centers’ Annual MeetingJune 15th, 2016
  • Join now to see all

Grant Support

  • Deep Sequencing For The Detection Of Viral Sequences In Primary Progressive MultiNational Institute Of Neurological Disorders And Stroke2011
  • STI And Respiratory Pathogen Testing In Nontraditional SettingsNational Institute Of Allergy And Infectious Diseases2009–2011
  • A Novel Genetic Therapy For Herpes KeratitisNational Eye Institute2004–2006
  • IL-6 In Herpes Simplex Virus Type 1 Ocular ReactivationNational Eye Institute1998–2002
  • Randomized, Double Blind Study Of 1,25dihydroxy Vitamin D3 And Influenza VaccineNational Center For Research Resources1998–1999
  • Randomized, Double Blind Study Of 1,25dihydroxy Vitamin D3 And Influenza Vaccin ENational Center For Research Resources1997

Dr. John Kriesel, Dr. John Kriesel, MD, Dr. J Kriesel, Dr. John D. Kriesel